It should be noted that oxLDL levels in this study were measured using a 4E6 monoclonal antibody‐based ELISA, which specifically detected oxidatively modified epitopes on apoB‐100, but did not differentiate degrees of oxidation, potentially underestimating the heterogeneity of oxLDL species involved in MMD pathophysiology. Here, APOB is linked to multiminicore myopathy.